AGM/EGMJun 26, 2026, 06:41 AM
Takeda Shareholders Approve Dividend, Director Elections, and Bonuses
AI Summary
Takeda Pharmaceutical Company Limited announced the results of its 150th Annual General Meeting of Shareholders held on June 24, 2026. Shareholders approved all proposed resolutions, including the appropriation of surplus for a year-end dividend of 100 JPY per share. The election of eight Directors who are not Audit and Supervisory Committee Members, three Directors who are Audit and Supervisory Committee Members, and one Substitute Director was also approved. Additionally, the payment of bonuses totaling up to 260 million JPY to eligible Directors was sanctioned.
Key Highlights
- Shareholders approved a year-end dividend of 100 JPY per share with 98.45% approval.
- Eight Directors who are not Audit and Supervisory Committee Members were elected, with approval rates ranging from 92.54% to 98.19%.
- Three Directors who are Audit and Supervisory Committee Members were elected, with approval rates from 91.81% to 98.20%.
- Paul Stoffels was elected as a Substitute Director who is an Audit and Supervisory Committee Member with 98.50% approval.
- Payment of bonuses up to 260 million JPY to Directors who are not Audit and Supervisory Committee Members was approved with 82.94%.
Price Impact
More from TAK